Clinical Trial Update: Stimulation Test With Intranasal Glucagon for Corticotroph, Somatotroph and Antidiuretic Axes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intranasal glucagon stimulation test for corticotroph, somatotroph, and antidiuretic axes in hypopituitarism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopituitarism

Drugs mentioned

• intranasal glucagon (glucagon)

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Hypopituitarism | Phase 4 | Status: COMPLETED